GMAB Genmab A/S
$50.97
Genmab A/S (GMAB) Earnings News
Earnings press releases, previews and reviews for Genmab A/S (GMAB), newest first. Our most recent is review: Genmab Tops EPS Estimates as Phase 3 Wins Overshadow Slowing Profit Growth and Flat Epkinly Sales.
Thursday
November 5, 2026
4:47 PM ET
Genmab Tops EPS Estimates as Phase 3 Wins Overshadow Slowing Profit Growth and Flat Epkinly Sales
Earnings Whispers · Review
Thursday
November 5, 2026
11:01 AM ET
Genmab Announces Financial Results for the Nine Months of 2026
Thursday
August 6, 2026
11:01 AM ET
Genmab Announces Financial Results for the First Half of 2026